Biotech Values

[poorgradstudent]

MDVN / Xtandi

I am not sure I understand. By looking at (the smoothness of) the time to chemo graph, I can see that a large number of patients used chemo in the Xtandi arm.

From the slides today, 40.3% of patients on xtandi went on a subsequent therapy versus 70.3% on the placebo arm. Specifically, 32.8% on the xtandi arm and 56.7% on the placebo arm received subsequent docetaxel.